Skip to main content

Huber switches on solar array

J.M. Huber has completed the set-up of a 1.8megawatt (DC), ground-mounted solar array located at the Huber Engineered Materials (HEM) Fire Retardant Additives Marblehead facility in Quincy, Illinois. The facility is now receiving more than 60% of its power from the array during daylight hours.

Indorama issues sustainability-linked bond

Thailand’s Indorama Ventures (IVL) has become the latest chemical company to issue a sustainability-linked bond (SLB). Worth THB 10 billion (€260 million), this is the largest issued to date in Thailand and the first offered to both institutions and high-net-worth investors.

New ADC technology from Merck KGaA

Merck KGaA’s Life Science business sector has launched ChetoSensar, a technology that improves the solubility of antibody-drug conjugates (ADCs). Over 20% of ADC candidates are terminated in clinical trials because of poor solubility. The company said that this supports it efforts to double its ADC and HPAPI capacity in the near future.

Ecolab to acquire Purolite

Ecolab has agreed to acquire Purolite, a supplier of ion exchange resins for the separation and purification of solutions based in Pennsylvania, for $3.7 billion in cash. This should close within Q4, subject to regulatory clearance and other closing conditions. It is expected to be revenue-neutral in 2022 and slightly accretive in 2023.

Purolite operates in more than 30 countries and employs about 1,000 people, with expected 2021 sales of around $400 million. It will operate as a separate global business unit and it results will be reported within the Life Sciences division.

Olon in enzymatic expansion

In partnership with Aguettant Pharmarmaceutical, Italy’s Olon Group is to expand and renovate its plant in Mulazzano, which is dedicated to the production by enzymatic transformation. It will install reactors, filters and ancillary equipment, as well as automating and digitalising some steps performed there.

Sitagliptin supply deal signed

Following on from the extension of a long-standing supply agreement with Merck & Co. for a proprietary enzyme used in the manufacture of sitagliptin, Codexis has reached a manufacturing agreement with two other firms. Sitagliptin is the API in Merck’s Januvia and one of the APIs in Janumet.

Albemarle’s Chinese lithium drive

Shortly after acquiring a lithium converter in Guangxi province, Albemarle has signed investment agreements that will enable it go build two lithium hydroxide plants in China. Each will have 50,000 tonnes/year of capacity and construction is to be completed by the end of 2024.

They are located at the Yangtze River International Chemical Industrial Park within the Zhangjiagang Free Trade Zone in Jiangsu province and the Pengshan Economic Development Park in the Pengshan district in Sichuan province.

Subscribe to Current issue